Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mister Goody, Inc. (OTCBB:MSGO) is providing the following corporate update regarding its partially owned subsidiary, The Naked Edge, LLC:
Naked Edge manufactures Veggie Go's, an organic fruit and vegetable snack currently sold at more than 600 retail locations in the United States and Canada, including Whole Foods, Abe's Market, Earth Saves, Vitamin Cottage, Lassen's, PCC Market, King Soopers, City Market and other chains and specialty stores.
Maybe he's out working!!!
Looking good
FDFT shorts getting caught
Looking good....
RCGP...The Radiant Creations Group, Inc. Elects Major General John A. Leide (US Army Retired) to Its Board of Directors
RCGP...The Radiant Creations Group, Inc. Elects Major General John A. Leide (US Army Retired) to Its Board of Directors
RCGP...The Radiant Creations Group, Inc. Elects Major General John A. Leide (US Army Retired) to Its Board of Directors
RCGP!! News!!
Looking good!! .001
RCGP
LAKE PARK, FL, Oct 31, 2013 (Marketwired via COMTEX) -- The Radiant Creation Group, Inc. (OTCBB: RCGP) ("Radiant") ("RCGP"), developer of unique, proprietary scientific technologies and cosmetic over-the-counter products, is pleased to provide the market with its second quarter financials for the period ending August 31, 2013. The full 10-Q filing is available on the SEC's website:
http://www.sec.gov/Archives/edgar/data/1372184/000126246313000703/00 01262463-13-000703-index.htm
Second quarter ending August 31, 2013 provided initial revenue of $37,672; the revenue was the first revenue the Company has achieved following the change in control. Net loss for the quarter ended August 31, 2013 was $1,031,484, which included $795,489 of one-time cost and accounting adjustments related to the asset purchase dated June 27, 2013.
On June 27, 2013, the Company entered into an Asset Purchase Agreement with The Renewable Corporation, a Washington corporation and its wholly owned subsidiary Renewable Bioscience Technologies, Inc., a Florida corporation to purchase their license, certain assets and processes to innovative technologies in skin protection from the sun, industrial UV sources (such as welding), and reducing collateral damage from medical radiation treatment which consists of various patented skin products. The purchase of the assets by the Company has been the key metric allowing the Company to generate its initial revenue. The initial revenue was generated by the sale of the recently completed Revivasol (www.revivasol.net) product.
Gary Smith, CEO, Radiant stated "We are proud to provide our financials to the investing public and to show our initial revenue. We were able to complete our first product, Revivasol, in the last week in August and we saw immediate sales. With Revivasol now completed we are looking forward to the rapid increase in revenue over the next months. We have worked meticulously to provide a compelling product for the cosmetics sector, to establish productive and elegant sales channels and to market Revivasol as aggressively as possible. Continued infusion of capital of investment capital will help fuel the growth of the Company and enable us to complete the development of additional product lines for our customers."
About The Radiant Creations Group, Inc. (RCGP)
Radiant Creations has achieved exciting breakthroughs creating remarkable products in skin protection and hydration, anti-aging, liver health and weight balance by combining DNA technologies developed in the Western World and naturally acting traditional Chinese medicine ingredients believed never before used in western culture by any bioscience company.
("RCGP") (OTCBB: RCGP), developer of unique, proprietary scientific technologies and cosmetic over-the-counter products, is pleased to announce the launch of our direct to consumer sales model.
("RCGP") (OTCBB: RCGP), developer of unique, proprietary scientific technologies and cosmetic over-the-counter products, is pleased to announce the launch of our direct to consumer sales model.
LAKE PARK, FL, Nov 01, 2013 (Marketwired via COMTEX) -- The Radiant Creation Group, Inc. ("Radiant") ("RCGP") (OTCBB: RCGP), developer of unique, proprietary scientific technologies and cosmetic over-the-counter products, is pleased to announce the launch of our direct to consumer sales model.
Radiant, through our exceptionally unique marketing and production process for sales and product distribution, is launching our direct to consumer model by mid November 2013. The Company is conservatively targeting about 100 units per day for the first 60 days and then ramping up to 150 sales per day by the end of our fiscal year ending February 28, 2014. It is the Company's position to aggressively ramp up sales of our recently completed Revivasol product (www.revivasol.net). Unit sales at this projected level represent gross monthly revenues in excess of $300,000 by the end of the February 28, 2014 year end.
"We have diligently worked on our direct to consumer sales model over the last few months and are pleased to announce that we have all of the key components ready to launch. We are excited to demonstrate to our shareholders and the investing public our ability to market our product to a worldwide audience. With our sales goals at 100 units per day and growing to 150 units per day, we will rapidly drive this company to profitability," stated Manpreet Singh Thaper, COO, The Radiant Creations Group, Inc.
RCGP
RCGP
Advisors
Yin-Xiong Li
MD., Ph.D., Professor
Dr. Li is currently a Chief Medical Officer and head of Guangzhou Institute of Biomedicine and Health in China, which covers all medical research and technical recommendations for over 800,000 related facilities. He is currently involved in setting up a licensing joint venture between Pfizer and the Chinese Government for a cancer-inhibiting drug. Dr. Li is further attempting to create a joint venture between China and the US to continue funding of his research to harvest adult stem cells, multiply the cells, and use them to eliminate the need for any liver transplants worldwide and other organ re-growth. Dr. Li was formerly an Assistant Professor, Dept. of Medicine (Gastroenterology and Cardiology), Pediatrics and Cell Biology, Duke University Medical School. Dr. Li has served on NIH grant boards and also was appointed to President Obama’s Stimulus Grant Board for medical research. He is considered one of the most productive geneticists in the world.
Dr. Li had the honor of his work being featured on the March 2007 cover of Nature’s “Laboratory Investigations Journal” for discovering a prevention for alcohol related birth defects. Dr. Li has developed a non-invasive monitor that can detect Fetal Alcohol Syndrome in pregnant women. The monitor also presents the technical promise of non-invasive sugar level testing and real time monitoring of critical parameters during anesthesia. After fourteen years of research, Dr. Li found and patented a method to prevent DNA damage in the skin from UV and radiation. This work has been developed into Renewable’s DNA sun block. It is expected to be used to lessen the risk of skin cancer from sunlight and to act a protection of skin during radiation procedures. Dr. Li has residences in both the US and China.
RCGP
Advisors
Yin-Xiong Li
MD., Ph.D., Professor
Dr. Li is currently a Chief Medical Officer and head of Guangzhou Institute of Biomedicine and Health in China, which covers all medical research and technical recommendations for over 800,000 related facilities. He is currently involved in setting up a licensing joint venture between Pfizer and the Chinese Government for a cancer-inhibiting drug. Dr. Li is further attempting to create a joint venture between China and the US to continue funding of his research to harvest adult stem cells, multiply the cells, and use them to eliminate the need for any liver transplants worldwide and other organ re-growth. Dr. Li was formerly an Assistant Professor, Dept. of Medicine (Gastroenterology and Cardiology), Pediatrics and Cell Biology, Duke University Medical School. Dr. Li has served on NIH grant boards and also was appointed to President Obama’s Stimulus Grant Board for medical research. He is considered one of the most productive geneticists in the world.
Dr. Li had the honor of his work being featured on the March 2007 cover of Nature’s “Laboratory Investigations Journal” for discovering a prevention for alcohol related birth defects. Dr. Li has developed a non-invasive monitor that can detect Fetal Alcohol Syndrome in pregnant women. The monitor also presents the technical promise of non-invasive sugar level testing and real time monitoring of critical parameters during anesthesia. After fourteen years of research, Dr. Li found and patented a method to prevent DNA damage in the skin from UV and radiation. This work has been developed into Renewable’s DNA sun block. It is expected to be used to lessen the risk of skin cancer from sunlight and to act a protection of skin during radiation procedures. Dr. Li has residences in both the US and China.
Ask free
MM gone
Nice close!!!
What a day....
TCEL break out!!!!!
Break Out!!!
FDFT!!! Looks like a good week
Go FDFT !!!!!!!!
Squeeze those shorts!!!!
Nice buys good by ..0011
Lots of rain in FL = lots of mold=$ for restore force
Ask can move if you blow on it
Tech play
Next big runner FDFT
Nice close
Great day!!!
Good call!!
Rocking!!!
experienced a nearly 500% growth in revenues, with additional revenue growth expected for all of 2013.
.0008 gone here comes .001's
I agree ... Needs a strong push